000			02048 a2200577 4500
005			20250516222931.0
264		0	_c20150525
008			201505s 0 0 eng d
022			_a2152-2669
024	7		_a10.1016/j.clml.2014.04.002 _2doi
040			_aNLM _beng _cNLM
100	1		_aIse, Mikiko
245	0	0	_aHepatic extramedullary disease in multiple myeloma with 17p deletion. _h[electronic resource]
260			_bClinical lymphoma, myeloma & leukemia _cOct 2014
300			_ae165-8 p. _bdigital
500			_aPublication Type: Case Reports; Journal Article
650	0	4	_aAneuploidy
650	0	4	_aAngiogenesis Inhibitors _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aBoronic Acids _xadministration & dosage
650	0	4	_aBortezomib
650	0	4	_aChromosome Aberrations
650	0	4	_aChromosome Deletion
650	0	4	_aChromosomes, Human, Pair 17 _xultrastructure
650	0	4	_aClone Cells _xchemistry
650	0	4	_aDexamethasone _xadministration & dosage
650	0	4	_aFatal Outcome
650	0	4	_aFemale
650	0	4	_aGene Deletion
650	0	4	_aGenes, p53
650	0	4	_aHumans
650	0	4	_aIncidental Findings
650	0	4	_aLenalidomide
650	0	4	_aLiver _xpathology
650	0	4	_aMiddle Aged
650	0	4	_aMultiple Myeloma _xchemistry
650	0	4	_aNeoplasm Proteins _xanalysis
650	0	4	_aNeoplasms, Multiple Primary
650	0	4	_aOsteolysis _xdiagnosis
650	0	4	_aProteasome Inhibitors _xadministration & dosage
650	0	4	_aPyrazines _xadministration & dosage
650	0	4	_aRecurrence
650	0	4	_aThalidomide _xadministration & dosage
650	0	4	_aTumor Suppressor Protein p53 _xanalysis
650	0	4	_aUterine Neoplasms _xsurgery
700	1		_aTsujimura, Hideki
700	1		_aSakai, Chikara
700	1		_aKumagai, Kyoya
773	0		_tClinical lymphoma, myeloma & leukemia _gvol. 14 _gno. 5 _gp. e165-8
856	4	0	_uhttps://doi.org/10.1016/j.clml.2014.04.002 _zAvailable from publisher's website
999			_c24002963 _d24002963